Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Colon Targeting Drug Delivery Market Today And What Is Its Future Size?

In recent times, there has been a robust growth in the size of the colon targeting drug delivery market. It’s estimated that this market, which was valued at $1.39 billion in 2024, will expand to $1.5 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Factors that contributed to this growth in the past include an increase in colorectal disease cases, an amplified emphasis on localized drug delivery, and the demand for better patient compliance, supplemented by the advent of biologics and peptides.

The market for colon targeted drug delivery is predicted to experience robust expansion in the upcoming years, with an expected rise to $2.03 billion by 2029 and a CAGR of 7.9%. This projected growth during the forecast period is largely due to the progression of stimuli-responsive and nanotechnology-based delivery systems, increased uptake of contract research and manufacturing services, accelerated approval routes and incentives provided by regulatory bodies, and the targeted delivery of biologics and biosimilars. Key trends for the forecasted period include advancements in pH-responsive techniques, the incorporation of personalized medicine, the application of artificial intelligence and digital tools in formulating designs, and a heightened emphasis on oral colon delivery.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24194&type=smp

What Drivers Are Accelerating Expansion Of The Colon Targeting Drug Delivery Market?

The growth of the colon targeting drug delivery market is predicted to be driven by the increasing occurrence of gastrointestinal diseases. These diseases, which impact the digestive tract, including the stomach, intestines, and other related organs, are on the rise due to unhealthy eating habits. This includes excessive consumption of processed foods and insufficient intake of fiber, which negatively affects digestion and gut health. To optimize therapeutic effectiveness and limit systemic side effects, colon targeting drug delivery is utilized in the treatment of gastrointestinal diseases, ensuring accurate drug release at the site of inflammation or infection. For example, Crohn’s and Colitis Canada, a nonprofit organization, stated in June 2023 that the number of individuals suffering from inflammatory bowel disease is expected to rise from 322,600 in 2023 (making up 0.8% of the population) to 470,000 by 2035 (constituting 1.1% of the population). As a result, the ascending rate of gastrointestinal diseases is stimulating the expansion of the colon targeting drug delivery market.

How Does The Colon Targeting Drug Delivery Market Differ By Segment?

The colon targeting drug delivery market covered in this report is segmented –

1) By Dosage Form: Tablets, Capsules, Microspheres, Nanoparticles, Other Dosage Form

2) By Technology: pH-Sensitive Systems, Time-Dependent Systems, Microbially Triggered Systems, Pressure-Controlled Systems, Other Technologies

3) By Application: Inflammatory Bowel Disease, Colorectal Cancer, Infectious Diseases, Other Application

4) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Tablets: Extended-Release Tablets, Enteric-Coated Tablets, Osmotic Pump Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Enteric-Coated Capsules

3) By Microspheres: Polymeric Microspheres, Biodegradable Microspheres, Non-biodegradable Microspheres

4) By Nanoparticles: Polymeric Nanoparticles, Solid Lipid Nanoparticles, Dendrimers, Lipid-Polymer Hybrid Nanoparticles

4) By Other Dosage Form: Films, Injections, Hydrogels, Suppositories

What New Opportunities Are Emerging From Trends In The Colon Targeting Drug Delivery Market?

Key companies in the colon targeting drug delivery market are focusing on the creation of innovative drug delivery methods, including functional oral dosage forms. These techniques are designed to enhance drug release targeting, boost healing effectiveness and lessen undesired side effects. Functional oral dosage forms are instrumental in this market, safeguarding active pharmaceutical ingredients (APIs) from breakdown within the upper gastrointestinal tract and assuring their regulated release specifically in the colon. A case in point is Evonik Industries AG, a specialty chemicals firm based in Germany that unveiled EUDRACAP Functional in September 2024. This is a state-of-the-art, ready-to-fill capsule technology designed for oral drugs’ targeted delivery to the colon. This advanced solution utilizes pH-sensitive polymers that dissolve only at particular intestinal pH levels, ensuring the APIs reach the colon fully intact. EUDRACAP Functional aids in the oral delivery of complex APIs such as peptides and probiotics, promoting the development of patient-friendly therapies. This expansion has amplified the potential for treating chronic gastrointestinal issues with increased precision and minimized systemic exposure.

Which Firms Are Making The Biggest Impact In The Colon Targeting Drug Delivery Market?

Major companies operating in the colon targeting drug delivery market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Lonza Pharma AG, Ferring Pharmaceuticals Company Limited, Salix Pharmaceuticals Ltd., Tillotts Pharma AG, BDD Pharma Ltd., Tharimmune Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/colon-targeting-drug-delivery-global-market-report

Which Region Is Leading Innovation In The Colon Targeting Drug Delivery Market?

North America was the largest region in the colon targeting drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colon targeting drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24194&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model